drugset / Trial / NCT00812006

A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis

NCT00812006 ↗

Phase 3 Completed 108 enrolled Organon and Co
RandomizedCrossoverDouble-blindTreatment

Summary

This study will provide additional efficacy data for rizatriptan when used for an acute migraine attack in patients already taking topiramate for migraine prophylaxis.

Timeline

Start
2009-03-24
Primary completion
2009-10-22
Completion
2009-10-22

Outcome

Met primary endpoint

paper Two-hour pain relief was significantly greater with rizatriptan compared with placebo (55.0% vs 17.4%, P < .001). PMID 22078129 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject rizatriptan Unknown 10 mg Oral

Indications